Skip to Content
Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

First Session, Forty-first Parliament, 2011-12-13

Chair: The Honourable KELVIN KENNETH OGILVIE


Wednesday, April 17, 2013
Thursday, April 18, 2013 (in camera)

Issue No. 36

Thirty-first and thirty-second meetings on:

Study on prescription pharmaceuticals in Canada


WITNESSES

Wednesday, April 17, 2013

Health Canada:

Dr. Marc Berthiaume, Director, Marketed Pharmaceuticals and Medical Devices Bureau, HPFB;

Dr. Supriya Sharma, Senior Medical Advisor, Health Products and Food Branch.

Canadian Institutes of Health Research:

Dr. Alain Beaudet, President;

Dr. Robert Peterson, Executive Director, Drug Safety and Effectiveness Network.


MEMBERS OF THE COMMITTEE

The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair

and

The Honourable Senators:

Cordy, *Cowan (or Tardif), Dyck, Enverga , *LeBreton, P.C. (or Carignan), Martin, Merchant, Munson, Patterson, Seidman, Seth, Verner, P.C.

* Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 12-5, membership of the committee was amended as follows:

The Honourable Senator Patterson replaced the Honourable Senator Black (April 18, 2013).

The Honourable Senator Seth replaced the Honourable Senator Maltais (April 18, 2013).

The Honourable Senator Maltais replaced the Honourable Senator Seth (April 17, 2013).

The Honourable Senator Black replaced the Honourable Senator Dagenais (April 17, 2013).

The Honourable Senator Dagenais replaced the Honourable Senator Eaton (April 17, 2013).